Elena Ridloff, C.F.A.

Elena Ridloff, C.F.A.

Chief Financial OfficeratSionna Therapeutics· In proxies 2023–2025

Pay in FY2025+120% from the year before

Elena Ridloff, C.F.A. was paid $2.9M in FY2025 (Dec), up 120%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Sionna Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sionna TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role -84%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?